1103 Results for "

Bioavailability

" in MedChemExpress (MCE) Product Catalog:
Products (1103)

1103 Results for "Bioavailability" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-15724A
CAS No.: 886214-18-2
Purity:  99.13%
Synonyms: GSK-1605786 sodium; CCX282-B sodium; Traficet-EN sodium
Target:  

CCR

Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9. Vercirnon sodium inhibits CCR9-mediated Ca 2+ mobilization and chemotaxis on Molt-4 cells with IC50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC50s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC50 values of 2.8 and 2.6 nM, respectively .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19984
CAS No.: 1607837-31-9
Target:  

CDK

Research Areas:  

Cancer

CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibitor with an IC50 of 2.3 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15343
CAS No.: 1257704-57-6
Purity:  99.77%
Target:  

JAK

Research Areas:  

Cancer

CEP-33779 is a novel, selective, and orally bioavailable inhibitor of JAK2 with an IC50 of 1.8±0.6 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13245
CAS No.: 1341224-83-6
Purity:  99.30%
Synonyms: INCB8761
Target:  

CCR

PF-4136309 is a potent, selective, and orally bioavailable CCR2 antagonist, with IC50s of 5.2 nM, 17 nM and 13 nM for human, mouse and rat CCR2.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-18175
CAS No.: 1404095-34-6
Research Areas:  

Cancer

CCT244747 is a potent, orally bioavailable and highly selective CHK1 inhibitor, with an IC50 of 7.7 nM; CCT244747 also abrogates G2 checkpoint with an IC50 of 29 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-16391
CAS No.: 1095173-27-5
Synonyms: PF-04449913
Target:  

Smo

Research Areas:  

Cancer

Glasdegib (PF-04449913) is a potent and orally bioavailable smoothened inhibitor. Glasdegib (PF-04449913) binds to human SMO (amino acids 181-787) with an IC50 of 4 nM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10302
CAS No.: 957116-20-0
Purity:  98.02%
Target:  

CGRP Receptor

Research Areas:  

Neurological Disease

MK-3207 (Hydrochloride) is a potent and orally bioavailable CGRP receptor antagonist with IC50 of 0.12 nM and Ki of 0.024 nM, and is highly selective versus human AM1, AM2, CTR, and AMY3.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-14291
CAS No.: 274901-16-5
Purity:  99.93%
Synonyms: LAF237; NVP-LAF 237
Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100226
CAS No.: 251992-66-2
Purity:  98.25%
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

A-205804 is an orally bioavailable, potent and selective lead inhibitor of E-selectin and ICAM-1 expression, with an IC50 of 20 nM and 25 nM for E-selectin and ICAM-1, respectively. A-205804 can be used in the research of chronic inflammatory diseases .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-141623
CAS No.: 2322245-49-6
Purity:  99.72%
Target:  

Arrestin

Research Areas:  

Metabolic Disease

SRI-37330 hydrochloride is an orally bioavailable thioredoxin-interacting protein (TXNIP) inhibitor. SRI-37330 hydrochloride inhibits glucagon secretion and function, reduces hepatic glucose production and reverses hepatic steatosis. SRI-37330 hydrochloride can be used for type 2 diabetes research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-142114
CAS No.: 2322245-42-9
Purity:  99.16%
Target:  

Arrestin

Research Areas:  

Metabolic Disease

SRI-37330 is an orally bioavailable thioredoxin-interacting protein (TXNIP) inhibitor. SRI-37330 inhibits glucagon secretion and function, reduces hepatic glucose production and reverses hepatic steatosis. SRI-37330 can be used for type 2 diabetes research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10300
CAS No.: 865466-24-6
Purity:  95.46%
Synonyms: SCH 900518
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM . Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease . Narlaprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.3 μM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112151
CAS No.: 2227996-00-9
Target:  

Complement System

Research Areas:  

Cancer

EG01377 is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of both 609 nM for NRP1-a1 and NRP1-b1. EG01377 has antiangiogenic, antimigratory, and antitumor effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112151A
CAS No.: 2749438-61-5
Purity:  98.98%
Target:  

Complement System

Research Areas:  

Cancer

EG01377 dihydrochloride is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of 609 nM for both NRP1-a1 and NRP1-b1. EG01377 dihydrochloride has antiangiogenic, antimigratory, and antitumor effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-110117
CAS No.: 213211-10-0
Purity:  99.82%
Research Areas:  

Inflammation/Immunology

BIRT 377 is a potent amd orally bioavailable inhibitor of the interaction between intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1). BIRT 377 also inhibits the production of IL-2 in vivo. BIRT 377 can be used for researching inflammatory and immune disorders .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-124593
CAS No.: 1256565-36-2
Purity:  99.89%
Synonyms: Emvododstat
PTC299 is an orally active inhibitor of VEGFA mRNA translation that selectively inhibits VEGF protein synthesis at the post-transcriptional level. PTC299 is also a potent inhibitor of dihydroorotate dehydrogenase (DHODH). PTC299 shows good oral bioavailability and lack of off-target kinase inhibition and myelosuppression. PTC299 can be useful for the research of hematologic malignancies .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-115340
CAS No.: 1002-62-6
Purity:  99.92%
Synonyms: Sodium decanoate; Sodium caprate
Decanoic acid sodium, also known as Decanoic acid sodium, is a salt of the fatty acid capric acid. It is easily soluble in water and has a slightly soapy smell. Decanoic acid sodium acts as a penetration enhancer, which means it increases the absorption and bioavailability of drugs across biological membranes, including the intestinal epithelium and the blood-brain barrier. This property makes it useful in pharmaceutical formulations to improve drug delivery and effectiveness. Furthermore, Decanoic acid sodium has potential applications in food preservatives and cosmetics due to its antibacterial properties.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10209
CAS No.: 790299-79-5
Purity:  99.95%
Synonyms: AB1010
Research Areas:  

Cancer

Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10209A
CAS No.: 1048007-93-7
Purity:  99.51%
Synonyms: AB-1010 mesylate
Target:  

c-Kit PDGFR Src FGFR Apoptosis

Research Areas:  

Cancer

Masitinib mesylate (AB-1010 mesylate) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib mesylate (AB-1010 mesylate) has anti-proliferative, pro-apoptotic activity and low toxicity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100014
CAS No.: 1905481-36-8
Purity:  99.64%
Target:  

Histone Demethylase

Research Areas:  

Cancer

KDM5A-IN-1 is a potent, orally bioavailable pan-histone lysine demethylases 5 (KDM5) inhibitor with IC50s of 45 nM, 56 nM and 55 nM for KDM5A, KDM5B and KDM5C, respectively, and with an EC50 value of 960 nM for PC9 H3K4Me3. KDM5A-IN-1 is significantly less potent against other KDM5B enzymes (1A, 2B, 3B, 4C, 6A, 7B) .
loading...
    loading...